Boston Scientific NIR Primo Monorail Rapid-Exchange Stent Rolls Out In U.S.
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's immediate market release of the NIR Primo Monorail coronary stent system brings to an end U.S. stent market leader Guidant's monopoly of the rapid-exchange niche of the domestic stent market.